OBJECTIVE: To examine maternal characteristics associated with adverse pregnancy outcomes among women infected with HIV. DESIGN: Prospective cohort study. SETTING: Multiple sites in Latin America and the Caribbean. POPULATION: Women infected with HIV enrolled in the Perinatal (2002-2007) and the Longitudinal Study in Latin American Countries (LILAC; 2008-2012) studies of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) International Site Development Initiative (NISDI). METHODS: Frequencies of adverse pregnancy outcomes assessed among pregnancies. Risk factors investigated by logistic regression analysis. MAIN OUTCOME MEASURES: Adverse pregnancy outcomes, including preterm delivery (PT), low birthweight (LBW), small for gestational age (SGA), stillbirth (SB), and neonatal death. RESULTS: Among 1512 women, 1.9% (95% confidence interval, 95% CI, 1.3-2.7) of singleton pregnancies resulted in a stillbirth and 32.9% (95% CI 30.6-35.4) had at least one adverse pregnancy outcome. Of 1483 singleton live births, 19.8% (95% CI 17.8-21.9) were PT, 14.2% (95% CI 12.5-16.1) were LBW, 12.6% (95% CI 10.9-14.4) were SGA, and 0.4% (95% CI 0.2-0.9) of infants died within 28 days of birth. Multivariable logistic regression modelling indicated that the following risk factors increased the probability of having one or more adverse pregnancy outcomes: lower maternal body mass index at delivery (odds ratio, OR, 2.2; 95% CI 1.4-3.5), hospitalisation during pregnancy (OR 3.3; 95% CI 2.0-5.3), hypertension during pregnancy (OR 2.7; 95% CI 1.5-4.8), antiretroviral use at conception (OR 1.4; 95% CI 1.0-1.9), and tobacco use during pregnancy (OR 1.7; 95% CI 1.3-2.2). The results of fitting multivariable logistic regression models for PT, LBW, SGA, and SB are also reported. CONCLUSIONS: Women infected with HIV had a relatively high occurrence of adverse pregnancy outcomes, and some maternal risk factors were associated with these adverse pregnancy outcomes. Interventions targeting modifiable risk factors should be evaluated further.
OBJECTIVE: To examine maternal characteristics associated with adverse pregnancy outcomes among women infected with HIV. DESIGN: Prospective cohort study. SETTING: Multiple sites in Latin America and the Caribbean. POPULATION: Women infected with HIV enrolled in the Perinatal (2002-2007) and the Longitudinal Study in Latin American Countries (LILAC; 2008-2012) studies of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) International Site Development Initiative (NISDI). METHODS: Frequencies of adverse pregnancy outcomes assessed among pregnancies. Risk factors investigated by logistic regression analysis. MAIN OUTCOME MEASURES: Adverse pregnancy outcomes, including preterm delivery (PT), low birthweight (LBW), small for gestational age (SGA), stillbirth (SB), and neonatal death. RESULTS: Among 1512 women, 1.9% (95% confidence interval, 95% CI, 1.3-2.7) of singleton pregnancies resulted in a stillbirth and 32.9% (95% CI 30.6-35.4) had at least one adverse pregnancy outcome. Of 1483 singleton live births, 19.8% (95% CI 17.8-21.9) were PT, 14.2% (95% CI 12.5-16.1) were LBW, 12.6% (95% CI 10.9-14.4) were SGA, and 0.4% (95% CI 0.2-0.9) of infants died within 28 days of birth. Multivariable logistic regression modelling indicated that the following risk factors increased the probability of having one or more adverse pregnancy outcomes: lower maternal body mass index at delivery (odds ratio, OR, 2.2; 95% CI 1.4-3.5), hospitalisation during pregnancy (OR 3.3; 95% CI 2.0-5.3), hypertension during pregnancy (OR 2.7; 95% CI 1.5-4.8), antiretroviral use at conception (OR 1.4; 95% CI 1.0-1.9), and tobacco use during pregnancy (OR 1.7; 95% CI 1.3-2.2). The results of fitting multivariable logistic regression models for PT, LBW, SGA, and SB are also reported. CONCLUSIONS:Women infected with HIV had a relatively high occurrence of adverse pregnancy outcomes, and some maternal risk factors were associated with these adverse pregnancy outcomes. Interventions targeting modifiable risk factors should be evaluated further.
Authors: Edgardo G Szyld; Eduardo M Warley; Laura Freimanis; René Gonin; Pedro E Cahn; Guilherme A Calvet; Geraldo Duarte; Victor H Melo; Jennifer S Read Journal: AIDS Date: 2006-11-28 Impact factor: 4.177
Authors: Rakhi Kohli; Yungtai Lo; Peter Homel; Timothy P Flanigan; Lytt I Gardner; Andrea A Howard; Anne M Rompalo; Galina Moskaleva; Paula Schuman; Ellie E Schoenbaum Journal: Clin Infect Dis Date: 2006-05-25 Impact factor: 9.079
Authors: Anna Suy; Esteban Martínez; Oriol Coll; Montserrat Lonca; Montserrat Palacio; Elisa de Lazzari; María Larrousse; Ana Milinkovic; Sandra Hernández; José L Blanco; Josep Mallolas; Agathe León; Juan A Vanrell; José M Gatell Journal: AIDS Date: 2006-01-02 Impact factor: 4.177
Authors: M L Dreyfuss; G I Msamanga; D Spiegelman; D J Hunter; E J Urassa; E Hertzmark; W W Fawzi Journal: Am J Clin Nutr Date: 2001-12 Impact factor: 7.045
Authors: Esaú C João; R Leavitt Morrison; David E Shapiro; Nahida Chakhtoura; Maria Isabel S Gouvèa; Maria de Lourdes B Teixeira; Trevon L Fuller; Blandina T Mmbaga; James S Ngocho; Boniface N Njau; Avy Violari; Ruth Mathiba; Zaakirah Essack; Jose Henrique S Pilotto; Luis Felipe Moreira; Maria Jose Rolon; Pedro Cahn; Sinart Prommas; Timothy R Cressey; Kulkanya Chokephaibulkit; Peerawong Werarak; Lauren Laimon; Roslyn Hennessy; Lisa M Frenkel; Patricia Anthony; Brookie M Best; George K Siberry; Mark Mirochnick Journal: Lancet HIV Date: 2020-05 Impact factor: 12.767
Authors: Wenwen Jiang; Keshet Ronen; Lusi Osborn; Alison L Drake; Jennifer A Unger; Daniel Matemo; Daniel A Enquobahrie; John Kinuthia; Grace John-Stewart Journal: AIDS Date: 2022-03-04 Impact factor: 4.632
Authors: Regis Kreitchmann; Karen Megazzini; Victor Hugo Melo; Débora Fernandes Coelho; D Heather Watts; Margot Krauss; Maria Isabel Gouvea; Geraldo Duarte; Marcelo H Losso; George K Siberry Journal: AIDS Care Date: 2015-08-19
Authors: Daniel Westreich; Jordan Cates; Mardge Cohen; Kathleen M Weber; Dominika Seidman; Karen Cropsey; Rodney Wright; Joel Milam; Mary A Young; C Christina Mehta; Deborah R Gustafson; Elizabeth T Golub; Margaret A Fischl; Adaora A Adimora Journal: AIDS Date: 2017-02-20 Impact factor: 4.177
Authors: Ingrid J M Snijdewind; Colette Smit; Mieke H Godfried; Rachel Bakker; Jeannine F J B Nellen; Vincent W V Jaddoe; Elisabeth van Leeuwen; Peter Reiss; Eric A P Steegers; Marchina E van der Ende Journal: PLoS One Date: 2018-01-19 Impact factor: 3.240
Authors: Martina L Badell; Anandi N Sheth; Florence Momplaisir; Lisa Rahangdale; JoNell Potter; Padmashree C Woodham; Gweneth B Lazenby; William R Short; Scott E Gillespie; Nevert Baldreldin; Emily S Miller; Gregg Alleyne; Lunthita M Duthely; Stephanie M Allen; Judy Levison; Rana Chakraborty Journal: Open Forum Infect Dis Date: 2019-03-18 Impact factor: 3.835
Authors: Jesse F Mangold; Ria Goswami; Ashley N Nelson; David R Martinez; Genevieve G Fouda; Sallie R Permar Journal: Pediatr Infect Dis J Date: 2021-05-01 Impact factor: 3.806